Moderna

Canada has already purchased 12 million doses of Moderna's version of the Omicron vaccine,which includes converting some existing orders for the original Moderna vaccine so that the newly adapted version will be delivered instead.

Moderna says construction of its new mRNA vaccine factory in the Montreal area will begin later this year, with production expected to begin by the end of 2024.

Canada's drug regulator approved Moderna's COVID-19 vaccine for infants and preschoolers on Thursday, July 14, 2022, making it the first vaccine approved for that age group in the country.

Canada is about to toss more than half of its doses of the Oxford-AstraZeneca COVID-19 vaccine because it couldn't find any takers for it either at home or abroad.

American vaccine maker Moderna is to announce today, April 29, 2022, it plans to build its promised Canadian production facility in Montreal.

Health Canada says almost 1.5 million doses of COVID-19 vaccines held in a national inventory have expired since January.

Canada has delivered about one-quarter of the direct vaccine doses it has promised to help less wealthy countries and can't say when more doses will go out the door.

Health Canada can add a request from Moderna to Pfizer’s pending offer to vaccinate five- to 11-year-olds, as parents and youngsters in Canada already wait weeks longer than children in the United States for first COVID-19 jabs.

Jennifer Hubert jumped at the opportunity to get her COVID-19 vaccine, but she’s not looking forward to having to make the decision about whether to vaccinate her three-year-old son Jackson.

Pfizer Canada says it plans to provide Health Canada with data showing its COVID-19 vaccine works for children in a bid to seek authorization "as early as possible."

In the debate over COVID-19 vaccine patents, a flawed logic is being used to justify putting profits above saving lives.

U.S. drug maker Moderna will sign an agreement with the Canadian government today, August 10, 2021, promising to build an mRNA production plant in Canada.

Procurement Minister Anita Anand says after talking to provinces, it was determined these COVID-19 doses were excess supply, as demand for this vaccine had been met. 

Officials and experts emphasized the interchangeability of the Moderna and Pfizer-BioNTech vaccines on Monday as shipment delays led to changes in Canadians' second-dose appointments.